Structure Therapeutics is developing a daily GLP-1 receptor pill called aleniglipron that just showed positive results from a ...

Scientists have observed the largest-known rotating structure in the cosmos - a gargantuan thread-like assemblage of hundreds ...

A radar engineer says multiple satellite operators produced matching tomography data that he believes shows large underground ...

Discover why Southern Company offers 12% upside and a 3.5% yield. Explore Q3 results, growth from data centers, and dividend ...

Discover why Structure Therapeutics Inc. is rated Strong Buy after positive Aleniglipron phase 2b obesity data. Click for ...

Watt’s online MSc Computer Science blends academic expertise with practical, real-world teaching, including algorithm demos ...

Here are 11 free NPTEL data science and analytics courses from leading IITs cover graph theory, Bayesian modelling, Python, R ...

Structure's aleniglipron elicited over 11% weight loss in a Phase II trial, sending the biotech's stock up nearly 103% as ...

Investing.com -- Structure Therapeutics Inc ADR (NASDAQ:GPCR) stock soared 28.8% in premarket trading Monday after the company announced positive topline data from its ACCESS clinical program for ...

Florida Power & Light has developed special rate structures to ensure data centers pay for their own infrastructure upgrades, ...

They are putting themselves to the fullest possible use, which is all I think that any conscious entity can ever hope to do.